Medline Growth Metrics (2025-2026) | MDLN

Growth Metrics Dec2025 Mar2026
Growth Ratios
Assets Growth (1y) (Quarter) 6.97%
Assets (QoQ) (Quarter) 1.38%
Capital Expenditures Growth (1y) (Quarter) -2.04%
Cash & Equivalents Growth (1y) (Quarter) 874.37%
Cash & Equivalents (QoQ) (Quarter) 15.32%
Cash from Investing Activities Growth (1y) (Quarter) -4.35%
Cash from Operations Growth (1y) (Quarter) -39.59%
EBITDA Margin Growth (1y) (Quarter) -315.00
EBIT Growth (1y) (Quarter) -26.09%
EBIT Margin Growth (1y) (Quarter) -285.00
EBT Growth (1y) (Quarter) -13.91%
EBT Margin Growth (1y) (Quarter) -113.00
Enterprise Value Growth (1y) (Quarter) 3,421.61%
Enterprise Value (QoQ) (Quarter) -11.63%
EPS (Basic) Growth (1y) (Quarter) 730.96%
EPS (Basic) (QoQ) (Quarter) 1,700.00%
EPS (Weighted Average and Diluted) (QoQ) (Quarter) 1,700.00%
FCF Margin Growth (1y) (Quarter) -449.00
Free Cash Flow Growth (1y) (Quarter) -45.89%
Gross Margin Growth (1y) (Quarter) -241.00
Gross Profit Growth (1y) (Quarter) 0.93%
Net Cash Flow Growth (1y) (Quarter) -47.85%
Net Income Growth (1y) (Quarter) -25.78%
Net Income towards Common Stockholders Growth (1y) (Quarter) -25.78%
Net Margin Growth (1y) (Quarter) -160.00
Operating Income Growth (1y) (Quarter) -26.09%
Operating Margin Growth (1y) (Quarter) -285.00
Profit After Tax Growth (1y) (Quarter) -25.08%
Profit After Tax (QoQ) (Quarter) 3,514.29%
Property, Plant & Equipment (Net) Growth (1y) (Quarter) 3.98%
Property, Plant & Equipment (Net) (QoQ) (Quarter) -0.42%
Return on Sales Growth (1y) (Quarter) 0.00
Revenue Growth (1y) (Quarter) 10.66%
Share-based Compensation Growth (1y) (Quarter) 21.05%
Shareholder's Equity Growth (1y) (Quarter) -33.55%
Shareholder's Equity (QoQ) (Quarter) 4.98%
Tax Rate Growth (1y) (Quarter) 1,314.00
Total Debt Growth (1y) (Quarter) -23.85%
Total Debt (QoQ) (Quarter) 0.09%